Although TNK has not been classified as a recommended class I thrombolytic agent in current stroke guidelines [10], increasing numbers of randomized controlled trials (RCTs) confirm the non-inferiority of TNK to ALT [17–20]. Here, GPT is linked to stroke disorder.